
The ABPI has expressed concerns over the remit of NICE International and its affect on global markets. NICE International is …

The head of NICE says pharma will face health technology assessment barriers in every country – including fast-growing developing markets. …
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

